Individuals should contact their GP or a relevant specialist before considering retatrutide if they have any of the following: A personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 (MEN2): Rodent studies with GLP-1 receptor agonists have identified thyroid C-cell changes
Recommended treatment protocol: 1000-2000 mcg of B12 given through injections or under the skin, at first daily or weekly
That can include advanced lab testing to review hormones, thyroid function, inflammation markers, and metabolic health, as well as a careful conversation about your symptoms, history, and day-to-day stressors
The angle of your needle, the speed of injection, the volume of water you choose, the way you dissolve the powder, even the temperature of the vials before you start